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Volume 49, Number 5S Poster Presentations 15SResults: 29/188 patients had an inappropriate bone window for TCD
and another 3 patients lacked data concerning clamp-to-shunt time. There
were no significant differences between the three groups in the following
characteristics: sex, age, co-morbidity, patch/no-patch and symptomatic/
asymptomatic patients (t-tests). 30-day stroke/death rate increased with
longer clamp-to-shunt time: 3,6%, 5,6% and 12,8% in group 1 (n28), 2
(n89), and 3 (n39), respectively. We analyzed this effect using a binary
logistic regression model and found a two-tailed p-value of 0,093. The
confounding effect of peri-operative microembolic signals and intracranial
flow decrease measured by TCD at 1 and 3 minutes after carotid cross
clamping was controlled for.
Conclusions: Longer carotid-clamp-to-shunt time tends to increase
30 day stroke/death rate post-CEA in our selective shunting protocol.
When clamp-to-shunt time exceeded 7 minutes, more than 1 out of 8
patients ended with stroke or death. Again, time is brain!
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PP4.
Routine Carotid Endarterectomy Without a Shunt Even in the Pres-
ence Of a Contralateral Occlusion: A Review of 2027 Procedures
Russell H Samson, David P Showalter, Michael R Lepore, Jr., Deepak G
Nair. Florida State University Medical School, Sarasota, FL
Objectives: A 20 year prospective experience with routine non-shunt-
ing during carotid endarterectomy (CEA), even in the presence of a con-
tralateral internal carotid artery occlusion, is reviewed.
Method: Carotid endarterectomy was performed under general anes-
thesiawithout a shunt in 2027 consecutive CEA procedures in1780 patients:
733 procedures were performed on females and 1294 on males with ages
ranging from 37 to 97 years and a mean age of 73 years. Monitoring of
cerebral blood flow and/or function was not utilized in any patient. Blood
pressure was maintained above 130mmHg pharmacologically. Heparin
(7500U) and protamine reversal were uniformly used.
Results: A contralateral occlusion was present in 127 CEAs. 1344
CEAs were performed with a Dacron patch. Average cross clamp time was
18.5 minutes and 21 minutes for CEA without and with patches respec-
tively (minimum 8 minutes and maximum 58 minutes). Average cross
clamp time in the presence of a contralateral occlusion was 19.6 minutes.
Overall, neurological complications occurred within thirty days in 33
(1.62%) patients (17 strokes [0.84%] and 16 transient ischemic attacks
(TIAs) [0.79%]). There was only one stroke in a patient with a contralat-
eral occlusion (0.79%). Immediate postoperative events, i.e. those that
could be implicated as due to lack of a shunt, were rare (0.89%) (10
strokes [0.49%] and 8 TIAs, [0.39%]). There were 12 perioperative
deaths (0.59%) 4 following a stroke (0.2%) and 7 (0.35%) due a cardiac
event.
Conclusion:Carotid endarterectomymay be performed safely without
a shunt even in the presence of a contralateral occlusion. Further, contralat-
eral occlusion does not appear to add additional risk to CEA and should not
be considered a high risk for endarterectomy.
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Urgent Surgical Treatment of Carotid Stenosis in Patients with Acute
Neurologic Deficits
Michele Carmo, Giulio Mercandalli, Alberto M Settembrini, Patrizia Lat-
tuada, George Prouse, Andrea Rignano, Pietro Bassi, Piergiorgio G Settem-
brini. S.Carlo Borromeo Hospital - Milan, Milan, Italy
Objective: Late results from NASCET and ECST showed a greater
benefit for surgery if performed within 4 weeks from symptoms. Recent
studies have emphasized the risk of stroke after TIAs and of stroke recur-
rence after a first episode. Our aim is to describe our experience in treating
symptomatic carotid stenosis in an emergency setting.
Methods: All patients admitted for acute neurologic deficits to the
StrokeUnit from 1/2002 to 9/2008were considered possible candidates to
surgery. Those treated within 36 hrs from positive carotid imaging studies
were reviewed. All patients received a brain CT and an ABCD2 or NIHSS
score, as appropriate. Surgery was not offered if NIHSS  22. TIA was
defined by deficits lasting  24 hrs and negative CT for 72 hrs. Stroke wasdefined by symptoms lasting  24 hrs or positive CT. Neurologic compli-
cations were defined by a worsening NIHSS or new area of brain ischemia at
CT. End points were perioperative death / neurological morbidity as per
NIHSS.
Results: Among 55 patients (40 male, mean age 699.8 yrs), 17
were admitted for TIA (3 amaurosis, 8 single TIA, 6 recurrent) with a
mean ABCD2 score of 3.21.6 at admission; 38 had a stroke (34 minor,
4 stroke in evolution), with a median NIHSS of 3 (IQR 2-7.5); 14 of
them had a positive CT. Median time from symptoms to observation was
4 hrs (2-7), from observation to surgery 34 hrs (9-115), with no
difference between TIAs and strokes. We performed 54 endarterectomies
(37 patch, 14 direct, 3 eversion) and 1 embolectomy. Local or regional
anesthesia was used in 20 patients and general in 35. Among TIAs 1
patient died of an MI and 2 patients suffered a TIA postoperatively. In
the stroke group 1 patient died of a cerebral hemorrhage arisen on 4th
postop day, being symptoms free until then. 2 patients had a TIA (1 arm
weakness and 1 amaurosis). 3 patients experienced a worsening NIHSS:
2 had a stroke while the third had a hyperperfusion syndrome (all CTs
negative during hospital stay). Median NIHSS at discharge was 2 (1-3).
Overall the death/stroke rate was 5.9% for TIA patients and 10.5% for
stroke.
Conclusions: Early surgery had higher perioperative mortality and
stroke rates than expected. This can probably be acceptable for TIAs if
compared to their risk of stroke. Stroke patients most likely need a better
selection in order to pick up those who can benefit from early treatment.
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Effectiveness of Pharmacologic Risk Modification in the Prevention of
Symptom Development in Patients with Asymptomatic Carotid Artery
Occlusive Disease
Panagiotis Kougias, Joanna Forbes, Tam T. Huynh, Carlos F. Bechara,
Catherine Cagiannos, Peter H Lin. Baylor College of Medicine, Houston,
TX
Objectives: Patients with carotid artery occlusive disease (CAOD) are
often not offered intervention under the notion that aggressive medical
management might reduce their risk of stroke. This study was undertaken to
investigate the effectiveness of multiagent treatment with antiplatelets,
statins, beta blockers, and angiotensin converting enzyme inhibitors (ACE
I) in the prevention of neurologic complications in patients with asymptom-
atic 60-79% internal carotid artery (ICA) stenosis.
Methods: Using a case-control design the medical regimen of 176
patients with 60-79% ICA stenosis who developed symptoms of stroke or
transient ischemic attack (TIA) was compared to that of 218 asymptomatic
patients with similar ICA stenosis range. Odds ratio (OR) and 95% confi-
dence intervals (CI) were calculated for each of the variables of interest,
whereas level of significance was determined with Fisher’s exact test. A
logistic regression equation that utilized interaction expansion variables was
modeled to assess combined effects of individual medication classes on the
development of neurologic symptoms.
Results: Both groups were matched for age, gender, range of
stenosis in the diseased carotid artery and the occurrence of hypertension,
hyperlipidemia, diabetes, coronary artery disease, smoking, and chronic
obstructive pulmonary disease. Cases were more likely to have a history of
stroke than the controls (OR: 2.07, CI: 1.17-3.68, p0.007). The odds
of developing either stroke or TIA was not affected by the use of
antiplatelets (OR: 1.4, CI: 0.85-1.93, p0.09), statins (OR: 1.02, CI:
0.66-1.58, p0.9), ACE I (OR: 0.82, CI: 0.54-1.25, p0.34), or beta
blockers (OR: 0.96, CI: 0.63-1.46, p0.85). The lack of correlation
persisted after adjustment for possible counfounding effect among the
different medication classes. The interaction logistic regression model
demonstrated that only the combination of antiplatelet with beta block-
ers decrease the odds for occurrence of symptoms (OR: 0.34, CI:
0.14-0.78, p0.011).
Conclusion: Multiagent pharmacotherapy does not provide a defini-
tive neurologic risk reduction in patients with moderate asymptomatic
carotid stenosis. Larger prospective studies are necessary to address the role
of pharmacotherapy in neurologic complication prevention among patients
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